December 11, 2009 07:41 ET

Better Mouse Trap Is Ready to Generate Hefty Profits for Biomedical Technology Solutions (OTC: BMTL)

LOS ANGELES, CA--(Marketwire - December 11, 2009) - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting that Biomedical Technology Solutions' (OTCBB: BMTL) medical waste disposal equipment presents small cap investors a great opportunity to get into the growing regulated medical waste sector which sees stocks trade at up to 25 times earnings (as compared to more typical 3 to 4 times earnings found in other sectors of the market).

"When I first saw the technology," explains Don Cox CEO of BioMedical Technology Solutions, "I thought 'what a simple, unique solution.' Then I started finding out just how much biomedical waste we produce in this country, when you found out how it grows it's staggering. 2006 numbers indicated that we had 1.5 billion pounds of the stuff produced commercially in the United States. That's five pounds for every person in the U.S. That equated to 3.5 billion dollars to haul that waste away commercially. That number has just kept growing since then."

According to some researchers, the world is 5 to 7 times larger than the U.S. market and that is just what they are able to gather from countries who are actually regulating and marking their waste.

"This is a market that is so massive and monstrous that there will never be any one individual company that will control it," says Cox who also realizes that if his company pushes a mere 25,000 Demolizer® units into the marketplace in a three to five year period, they will own less than three percent of the U.S. market. Yet that goal would easily give his company a half billion dollar market cap. Especially since their efficient operations and in-house manufacturing process provide the company a 65% gross margin operation.

It's difficult not to see shares of this company starting to trade higher almost immediately. Long term, this could turn out to be a great way for small-cap investors to get into the booming regulated medical waste market using a great upside, low-risk opportunity.

The complete report is available now at BioMedReports.Com: profits-otcbmtl.html

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:

About BioMedReports.Com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid, compensated or in any way incentivized to report news and developments about publicly traded companies.

For more biomedical sector and investment news go to

Contact Information

  • Media Contact:
    Mary Davila
    Assistant Editor, BioMedReports.Com
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556